ELIZABETH VERA: Open Payments
NPI 1093475329 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 37 payments from 13 companies in 2025. Trend: 2023 $545 · 2024 $805 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $174 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Dexcom, Inc. | 2 | $68 |
| Novo Nordisk Inc | 3 | $61 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| Medtronic, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: VRAYLAR, Dexcom G6 Transmitter, QULIPTA, INSPIRE, Ozempic, AIRSUPRA, Veozah, SYNTHROID.
Industry payments across GA — which companies pay providers there.
